{"id":"https://openalex.org/W10384284","doi":null,"title":"Therapeutic issues in oral glucocorticoid use.","display_name":"Therapeutic issues in oral glucocorticoid use.","publication_year":1999,"publication_date":"1999-05-01","ids":{"openalex":"https://openalex.org/W10384284","mag":"10384284","pmid":"https://pubmed.ncbi.nlm.nih.gov/10711134"},"language":"en","primary_location":{"id":"pmid:10711134","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10711134","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Lippincott's primary care practice","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5109830749","display_name":"C E Bello","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I203088144","display_name":"Nova Southeastern University","ror":"https://ror.org/042bbge36","country_code":"US","type":"education","lineage":["https://openalex.org/I203088144"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"C E Bello","raw_affiliation_strings":["Department of Pharmacy Practice, College of Pharmacy, Nova Southeastern University, Fort Lauderdale, FL 33328, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy Practice, College of Pharmacy, Nova Southeastern University, Fort Lauderdale, FL 33328, USA","institution_ids":["https://openalex.org/I203088144"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5109830750","display_name":"S D Garrett","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S D Garrett","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":18,"citation_normalized_percentile":{"value":0.00158547,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":93},"biblio":{"volume":"3","issue":"3","first_page":"333","last_page":"41; quiz 342"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12421","display_name":"Adrenal Hormones and Disorders","score":0.9878000020980835,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12421","display_name":"Adrenal Hormones and Disorders","score":0.9878000020980835,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13970","display_name":"Pharmacy and Medical Practices","score":0.0017000000225380063,"subfield":{"id":"https://openalex.org/subfields/3611","display_name":"Pharmacy"},"field":{"id":"https://openalex.org/fields/36","display_name":"Health Professions"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11839","display_name":"Hormonal Regulation and Hypertension","score":0.0015999999595806003,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/oral-corticosteroids","display_name":"oral corticosteroids","score":0.9679999947547913},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.8309999704360962},{"id":"https://openalex.org/keywords/hpa-axis-suppression","display_name":"HPA axis suppression","score":0.8870000243186951},{"id":"https://openalex.org/keywords/adrenal-crisis","display_name":"adrenal crisis","score":0.9879999756813049},{"id":"https://openalex.org/keywords/drug-induced-osteoporosis","display_name":"drug-induced osteoporosis","score":0.9629999995231628},{"id":"https://openalex.org/keywords/cataract","display_name":"cataract","score":0.8109999895095825},{"id":"https://openalex.org/keywords/hypertension","display_name":"hypertension","score":0.7990000247955322},{"id":"https://openalex.org/keywords/hyperglycemia","display_name":"hyperglycemia","score":0.9390000104904175},{"id":"https://openalex.org/keywords/hypercholesterolemia","display_name":"hypercholesterolemia","score":0.8600000143051147},{"id":"https://openalex.org/keywords/avascular-necrosis","display_name":"avascular necrosis","score":0.9739999771118164},{"id":"https://openalex.org/keywords/growth-retardation","display_name":"growth retardation","score":0.953000009059906},{"id":"https://openalex.org/keywords/myopathy","display_name":"myopathy","score":0.8190000057220459},{"id":"https://openalex.org/keywords/alternate-day-therapy","display_name":"alternate-day therapy","score":0.9900000095367432},{"id":"https://openalex.org/keywords/corticosteroid-tapering","display_name":"corticosteroid tapering","score":0.8999999761581421},{"id":"https://openalex.org/keywords/drug-interactions","display_name":"drug interactions","score":0.9739999771118164},{"id":"https://openalex.org/keywords/patient-monitoring","display_name":"patient monitoring","score":0.7160000205039978}],"concepts":[{"id":"https://openalex.org/C2780841215","wikidata":"https://www.wikidata.org/wiki/Q422549","display_name":"Glucocorticoid","level":2,"score":0.8071178197860718},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.7379240989685059},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7169009447097778},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.5368509888648987},{"id":"https://openalex.org/C2776541429","wikidata":"https://www.wikidata.org/wiki/Q165328","display_name":"Osteoporosis","level":2,"score":0.434650182723999},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.4219241738319397},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3555825650691986},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.28981393575668335}],"mesh":[{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000893","descriptor_name":"Anti-Inflammatory Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000893","descriptor_name":"Anti-Inflammatory Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D004347","descriptor_name":"Drug Interactions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004358","descriptor_name":"Drug Therapy","qualifier_ui":"Q000451","qualifier_name":"nursing","is_major_topic":false},{"descriptor_ui":"D005938","descriptor_name":"Glucocorticoids","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D005938","descriptor_name":"Glucocorticoids","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013256","descriptor_name":"Steroids","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013810","descriptor_name":"Therapeutic Equivalency","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016903","descriptor_name":"Drug Monitoring","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D016903","descriptor_name":"Drug Monitoring","qualifier_ui":"Q000451","qualifier_name":"nursing","is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:10711134","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10711134","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Lippincott's primary care practice","raw_type":"Journal Article"},{"id":"mag:10384284","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10711134","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2080443550","https://openalex.org/W4206559554","https://openalex.org/W18980706","https://openalex.org/W2021473664","https://openalex.org/W4389071787","https://openalex.org/W2259711313","https://openalex.org/W2615718476","https://openalex.org/W2040435914","https://openalex.org/W7214609178","https://openalex.org/W2116094716"],"abstract_inverted_index":{"The":[0,15],"therapeutic":[1],"use":[2],"of":[3,17,36,44,81],"glucocorticoids":[4],"are":[5,31,116],"extensive":[6],"despite":[7],"numerous":[8],"adverse":[9,84,114],"effects":[10,43],"related":[11],"to":[12,46,64],"their":[13],"use.":[14],"fear":[16],"hypothalamic-pituitary-adrenal":[18],"(HPA)":[19],"axis":[20],"suppression":[21],"and":[22,39,57,69],"adrenal":[23],"crisis":[24],"often":[25],"prolongs":[26],"glucocorticoid":[27,100,112],"therapy":[28,60,77],"unnecessarily.":[29],"Glucocorticoids":[30],"the":[32,47,79,92],"most":[33,83],"common":[34,99],"cause":[35],"drug-induced":[37],"osteoporosis":[38],"cataract":[40],"formation.":[41],"Other":[42],"concern":[45],"primary":[48],"care":[49],"provider":[50],"include":[51],"increased":[52],"blood":[53,55],"pressure,":[54],"glucose,":[56],"cholesterol.":[58],"Glucocorticoid":[59],"also":[61],"may":[62],"lead":[63],"avascular":[65],"necrosis,":[66],"growth":[67],"retardation,":[68],"myopathy.":[70],"Practical":[71],"dosing":[72],"strategies":[73],"such":[74],"as":[75],"alternate-day":[76],"reduce":[78],"risk":[80],"developing":[82],"effects.":[85],"Several":[86],"tapering":[87],"regimens":[88],"exist":[89],"that":[90],"lessen":[91],"potential":[93],"for":[94],"steroid":[95],"withdrawal":[96],"syndrome.":[97],"Identifying":[98],"drug":[101,104],"interactions":[102],"averts":[103],"toxicity.":[105],"By":[106],"appropriately":[107],"monitoring":[108],"patients":[109],"on":[110],"long-term":[111],"therapy,":[113],"outcomes":[115],"minimized.":[117]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2013,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}